|
|
Optimization of concentration determination of degrdation products of uracil via LC-MS
Kavale, Gustav ; Ševčík, Jan (advisor) ; Míšek, Jiří (referee)
In the Czech Republic, tens of thousands of oncology patients undergo treatment based on fluoropyrimidines every year. Many of these patients suffer from negative side effects that can even have a fatal impact. Currently, the best described factor in the cause of the toxicity of fluoropyrimidines is the activity of the pyrimidine catabolism enzyme - dihydropyrimidine dehydrogenase. Due to the high frequency of pathogenic mutations in the dihydropyrimidine dehydrogenase gene, the extreme risk of toxicity affects hundreds of patients in the Czech Republic every year. For this reason, the "European Medical Agency" has issued a recommendation to carry out investigations for the possible occurrence of toxic effects before starting treatment. One of the diagnostic options for determining sensitivity to fluorouracil is metabolomic analysis, based on the quantification of degradation products of uracil metabolism in plasma using liquid chromatography with mass spectrometry. The goal of this work is to perform basic optimization of mass spectrometer parameters for quantification of selected degradation products of uracil metabolism. Keywords: Uracil, Fluoruracil, Liquid Chromatography, Mass Spectrometry
|
guest ::
